FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
Pipeline-Powerpoint-Wide-8-18-23
© Copyright 2026 INOVIO Pharmaceuticals. All rights reserved.
